We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > OntoChem

News List

Anixa and OntoChem to enter next stage of Covid-19 therapy development pharmaceutical-technology
April 07, 2021
Anixa Biosciences and OntoChem are set to enter the next stage of developing their potential anti-viral therapy for Covid-19 on obtaining results from a Proof of Concept (POC) animal study.
Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates americanpharmaceuticalreview
February 19, 2021
Anixa Biosciences announced animal testing has commenced with two proprietary compounds that have shown potency in in vitro studies.
Anixa, OntoChem COVID-19 Therapy Demonstrates Comparable Potency to Remdesivir americanpharmaceuticalreview
December 15, 2020
Anixa Biosciences and OntoChem GmbH have verified one of their recently discovered compounds is similar in potency to remdesivir, the only approved anti-viral drug against SARS-Cov-2. As previously announced, Anixa and OntoChem had identified multiple ...
Anixa, OntoChem Announce Identification of Additional Covid-19 Compounds americanpharmaceuticalreview
August 18, 2020
Anixa Biosciences announced that the company and its partner, OntoChem, have identified additional candidates through their in silico screening study.